Novavax prices offering

Novavax (NVAX) prices a 27.7M share public offering at $3.14/share, for gross proceeds of $87M.

Underwriters have a 30-day, ~4.1M share option.

Proceeds will go towards advancing the company's clinical-stage vaccines. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs